DIN 02466236 — RYDAPT 25 MG
RYDAPT is a capsule of Midostaurin marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Midostaurin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02466236
- Brand name
- RYDAPT
- Active ingredient
- Midostaurin
- Strength
- 25 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- FLT3 kinase inhibitor / multi-kinase inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.